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Kaposi’s sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8) is
a major etiological agent for multiple severe malignancies in immune-compromised
patients. KSHV establishes lifetime persistence in the infected individuals and displays
two distinct life cycles, generally a prolonged passive latent, and a short productive or
lytic cycle. During latent phase, the viral episome is tethered to the host chromosome and
replicates once during every cell division. Latency-associated nuclear antigen (LANA) is
a predominant multifunctional nuclear protein expressed during latency, which plays a
central role in episome tethering, replication and perpetual segregation of the episomes
during cell division. LANA binds cooperatively to LANA binding sites (LBS) within the
terminal repeat (TR) region of the viral episome as well as to the cellular nucleosomal
proteins to tether viral episome to the host chromosome. LANA has been shown to
modulate multiple cellular signaling pathways and recruits various cellular proteins such
as chromatin modifying enzymes, replication factors, transcription factors, and cellular
mitotic framework to maintain a successful latent infection. Although, many other regions
within the KSHV genome can initiate replication, KSHV TR is important for latent DNA
replication and possible segregation of the replicated episomes. Binding of LANA to
LBS favors the recruitment of various replication factors to initiate LANA dependent
DNA replication. In this review, we discuss the molecular mechanisms relevant to KSHV
genome replication, segregation, and maintenance of latency.
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INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-
8), belongs to the γ-herpesvirus family. It is one of the seven recognized human cancer causing
viruses (Moore and Chang, 2010). KSHV is etiologically associated with Kaposi’s sarcoma (KS) as
well as two other cell proliferative cancers, Primary Effusion Lymphoma (PEL) and Multicentric
Castleman’s Disease (MCDs) (Chang et al., 1994; Cesarman et al., 1995). KS lesions are highly
complex and are characterized by proliferating spindle-shaped endothelial cells (ECs), neovascular
structures, leukocyte infiltrations (monocytes, lymphocytes, and mast cells), and an abundance of
inflammatory cytokines (ICs), growth factors, angiogenic factors, and invasive factors (Chang et al.,
1994; Valiya Veettil et al., 2014). KSHV genome exists as a linear dsDNA in the virion particles and
its size ranges from 165 to 170-kb (Renne et al., 1996; Neipel et al., 1998). The large KSHV genome
consists of a∼137 kb long unique region (LUR), encompassing the KSHVORFs, flanked by a 30-kb
terminal repeat sequences, which are reiterated copies of 801 bp sequence with high GC-content,
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important for multiple functions of the viral life cycle (Renne
et al., 1996; Russo et al., 1996; Duprez et al., 2007). Once
transported to the nucleus, the linear viral DNA rapidly
circularizes and is maintained as an episome upon infection.
KSHV LIFE CYCLE
Like many other members of the γ-herpesvirus family, KSHV
life cycle is divided into two distinct phases of infection, the
lytic phase and the default latent phase, which are characterized
by the patterns of viral gene expression (Ye et al., 2011). Both
latent and lytic cycle replication are important for the long-term
persistence of the virus in the host, and the gene products from
both expression programs serve critical roles in the pathogenesis
of KSHV-associated disease (Cesarman, 2002; Figure 1).
During latency, KSHV expresses a limited number of viral
genes, such as ORF73 (latency-associated nuclear antigen 1
[LANA-1]), ORF72 (viral Cyclin [vCyclin]), ORF71 (K13/vFLIP),
and ORFK12 (kaposins A, B, and C), along with 12 distinct
microRNAs, to facilitate the establishment of lifelong latency
in its host and survival against the host innate, and adaptive
immune surveillance mechanisms (Staskus et al., 1997; Dittmer
et al., 1998; McClure and Sullivan, 2008). KSHV encodes >86
open reading frames (ORFs), which includes at least 22 potential
immunomodulators, K3, K5, K9, K11.1, and anti-apoptotic K7
(viral Bcl-2) (Russo et al., 1996; Neipel et al., 1997), which
regulate cytokine secretion, antagonize host interferon (IFN)-
mediated antiviral responses, and regulate immune evasion
(Jenner et al., 2001; Valiya Veettil et al., 2014). During latency,
KSHV genome persists as a circular episome that subsequently
FIGURE 1 | Schematic representation of KSHV life cycle in infected cell.
KSHV life cycle comprises of two distinct phases of infection namely a short
lytic phase and a predominant latent phase. Maintaining a perfect balance
between latent and lytic phase is important for the long-term persistence of the
virus in the host, additionally specific gene products from both the expression
programs play crucial roles in the pathogenesis of KSHV-associated disease.
associates with cellular histones and exists as a non-integrated
minichromosome in the nucleus of infected cells (Toth et al.,
2013) with the expression of limited viral genes to maintain the
genome in dividing cells and to limit host immune responses
while enhancing cell survival and virus persistence (Cai et al.,
2010b). The latency associated viral products have an essential
role in the development of KSHV-associated malignancies
because most tumor cells in KS, PEL, and MCD are latently
infected by KSHV (Cesarman, 2002; Cotter and Robertson,
2002). KSHV latent cells can be reactivated into lytic replication
by specific intracellular or extracellular stimuli, chemicals that
affect chromatin regulatory factors such as valproic acid, hypoxia,
12-O-tetradecanoylphorbol-13-ace-tate (TPA), and butyrate (Yu
et al., 1999; Shaw et al., 2000; Davis et al., 2001), histone
deacetylases (HDACs), DNA methyltransferases (DNMTs), and
histone acetyltransferases (HATs) (Chen et al., 2001; Lu et al.,
2003; Xie et al., 2008), as a result of which, the viral episome
gradually relaxes its compact chromatin structure, leading to the
expression of all viral genes and the production of infectious
virions particles (Iyengar and Farnham, 2011). This indicates that
transition of KSHV life cycle involves viral chromatin remodeling
from the heterochromatin to the euchromatin state (Zhang et al.,
2014).
The first lytic genes to be expressed during lytic cycle
replication in B lymphocytes is an immediate early (IE) gene,
RTA (ORF50) (Gradoville et al., 2000), which triggers the
expression of early genes required for viral DNA replication
followed by the expression of late genes (Jenner et al., 2001;
Rossetto et al., 2007; Verma et al., 2015). Sequential expression
of these viral lytic products promotes cell proliferation,
angiogenesis, and local inflammation due to virus production
and shutdown of host cell protein synthesis, leading to the
initiation and progression of KS tumors (Pan et al., 2004;
Sadagopan et al., 2007; Ye et al., 2007). In latently infected
cells, RTA (replication and transcription activator) expression
is tightly restricted, suggesting that transcriptional repression of
RTA gene is needed to establish latency in the host (Katano et al.,
2001). Chromatin modification and nucleosome positioning
seem to be essential for inactivation as well as activation of
latent genes (Lu et al., 2006; Pantry and Medveczky, 2009).
Recent genome-wide analysis using ChIP-on-chip in conjunction
with immunoprecipitation of methylated DNA examining the
epigenetic landscape of KSHV genomes, showed that the KSHV
genomes undergo methylation at CpG nucleotide accompanied
by specific histone modification marks leading to a rapid
establishment of latency and silencing of lytic gene expression
(Günther and Grundhoff, 2010; Toth et al., 2010, 2013).
KSHV LATENCY PROGRAM
Modulation by viral factors plays a key role in maintaining
viral latency. Latent transcriptional program that has largely
been carried out in more than 90% of infected cells, has
led to the characterization of a major latency locus that is
abundantly and consistently transcribed in all latently KSHV-
infected cells (Dittmer et al., 1998; Burýsek and Pitha, 2001).
Since LANA, vCyclin, vFLIP, and the miRs are located in
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the latency locus of KSHV genome and are expressed during
latency, they are likely to contribute to KSHV latency (Burýsek
and Pitha, 2001; Dittmer et al., 1998). They are also involved
in KSHV induced malignant transformation and oncogenesis
by promoting cell growth and survival and the induction of
inflammatory cytokines.
Latency-Associated Nuclear Antigen
(LANA)
Latency-associated nuclear antigen (LANA) encoded by ORF73
is the major latent protein strongly expressed in all forms of
KSHV-associated malignancies throughout the viral life cycle
(Rainbow et al., 1997; Gao et al., 1999). LANA is essential
for KSHV episomal replication, maintenance, and efficient
segregation of episomal DNA into the daughter cells during
mitosis (Hu et al., 2002; Si et al., 2008). LANA is amultifunctional
nuclear protein with 1162 amino acids and 220–230 kDa in
size that interacts with various cellular as well as viral proteins,
including tumor suppressors, p53 (Friborg et al., 1999) and pRb
(Radkov et al., 2000), transcription factors such as ATF4/CREB2
(Lim et al., 2000) and STAT3 (Muromoto et al., 2006), cellular
signal transducer, GSK-3ß (Fujimuro and Hayward, 2003;
Fujimuro et al., 2003), chromatin-binding proteins such as HP1
(Lim et al., 2003), histone H2A/B (Barbera et al., 2006), MeCP2
(Matsumura et al., 2010), and Brd4 (Ottinger et al., 2006).
LANA Mediated Cellular Signaling
For the successful establishment of latency, KSHV is armed
to manipulate multiple viral and cellular signaling pathways
to repress KSHV reactivation and to escape the host immune
surveillance (reviewed in, Verma et al., 2007c; Cai et al., 2010b).
KSHV LANA directly deregulates various cellular signaling
pathways (Verma et al., 2004; Lan et al., 2005) such as MAPK,
JAK/STAT, MEK/ERK, PI3K/AKT, Notch, and Wnt signaling to
establish latency (Figure 2).
MAPK Pathway
The majority of the pathways activated after KSHV infections
include, JNK, MEK-ERK, and p38 mitogen activated protein
kinase (MAPK). The establishment of persistent infection
depends on the activation of these cellular signaling pathways
(Sharma-Walia et al., 2005; Pan et al., 2006). Similarly,
reactivation of latently infected cells leads to the activation
of MAPK pathways (Ford et al., 2006; Yu et al., 2007; Xie
et al., 2008). KSHV LANA is involved in the activation of
the serum response element and MAPK pathways through its
interaction with a mediator complex (Roupelieva et al., 2010).
During de novo KSHV infection heat shock protein 90 (hsp90)
triggers latent gene expression and also acts as a cofactor for
MAPK activation by localizing to the cellular surface (Qin et al.,
2010a). Recently, a screening of the human kinome identified the
significance of MSK1/2-CREB1 pathway in KSHVmediated lytic
replication after the onset of infection (Cheng et al., 2015). These
studies suggest that MAPK pathways play a critical role in KSHV
infection as well as in lytic reactivation.
JAK-STAT Pathway
The cellular growth, differentiation and immune response
is controlled by cytokine dependent JAK-STAT signaling.
Constitutive activation of the receptor associated Janus tyrosine
kinases are the consequence of KSHV infection leading to
the phosphorylation of signal transducers and the activators
of transcription (STATs) (Punjabi et al., 2007). The expression
of gp130 receptor is induced during KSHV infection leading
to the phosphorylation of JAK2/STAT3 (Punjabi et al., 2007;
Morris et al., 2008). The role of LANA and vGPCR has been
well documented in regulating JAK2/STAT3 signaling, which
ultimately leads to the release of various angiogenic factors
(Burger et al., 2005; Muromoto et al., 2006). The role of activated
IL13/STAT6 signaling contributes to the cellular survival and
proliferation after KSHV infection (Wang et al., 2015). The
inhibition of this pathway leads to the inhibition of PELs survival
and proliferation (Wang et al., 2015). KSHV LANA inhibits
IL4-STAT6 signaling during apoptotic stress and in order to
establish latency (Cai et al., 2010a). Also, IL-4/STAT6 signaling
can regulate the reactivation of KSHV (Zeng et al., 2007).
Notch Signaling
Notch signaling pathway is involved in the determination of
cell fate during stem cell maintenance, tissue homeostasis and
development (Artavanis-Tsakonas et al., 1999; Lai, 2004). The
latently infected cells are driven toward angiogenesis by LANA
through targeting Hey1 (notch signaling effector; Wang et al.,
2014). The levels of the components belonging to the Notch
signaling cascades are higher in KS lesions and the experimental
lesions are sensitive to the Notch pathway inhibitors (Curry et al.,
2005, 2007). Notch signaling pathway is essential for KSHV’s
entry into lytic phase as well as for the cellular survival of
the infected cells. The RTA protein of KSHV binds to RBP-Jκ,
which is an essential component of Notch signal transduction
pathway (Liang et al., 2002; Persson and Wilson, 2010). LANA
targets sel10 protein in order to stabilize the activated forms
of Notch receptors (Lan et al., 2007). KSHV infection increases
the expression of Notch ligands (JAG1 and DLL4) through
the expression of KSHV genes during latent and lytic phases
of infection (Emuss et al., 2009). These studies conclusively
show that KSHV infection influences cellular differentiation and
proliferation by regulating Notch signaling cascade.
HIF Signal Transduction
Hypoxia-inducible factor (HIF) is one of the transcriptional
regulators, which leads to the transcription of various
genes related to angiogenesis and tumorous growth. HIF
is heterodimeric in structure with α (inducible) and β
(constitutively expressed) subunits (Ke and Costa, 2006).
Generally, the isoforms of HIFα has been categorized into three
forms (HIF1α, HIF2α, and HIF3α) in humans (Ke and Costa,
2006). HIFα is hydroxylated and ubiquitinated in the presence
of oxygen (Maxwell et al., 1999; Ravi et al., 2000), whereas the
hydroxylation of HIFα is suppressed under hypoxic conditions
leading to its enhanced stability and transcription of downstream
genes involved in glycolysis, erythropoiesis and angiogenesis
(Seagroves et al., 2001; Lee et al., 2004). The HIFα is highly
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FIGURE 2 | Diagrammatic representation of the cellular signaling pathways in maintaining latency. KSHV genome persists as a latent episome within the
infected cells by expressing a limited number of viral genes during latency. For a successful establishment of latency, KSHV manipulates and deregulates multiple viral
and cellular signaling pathways. KSHV latent genes, including LANA, vFLIP, miRNA, and vCyclin activate and maintain various cytokine-mediated cell proliferation and
tumorigenesis pathways, such as MAPK, JAK/STAT, MEK/ERK, PI3K/AKT/mTOR, Notch, Wnt, cMyc, p53, RB, and NF-κB, to maintain latent infection.
expressed due to the induction of HIF signaling in various
cancerous cells with vascularized and tumorous properties
(Zhong et al., 1999; Zagzag et al., 2000). The expression of
HIF1α and HIF2α are higher in latently infected cells during
KSHV infection (Carroll et al., 2006; Cai et al., 2007). Also, the
hypoxia mediated KSHV reactivation is induced through KAP1
inhibition. The suppression of KAP1 leads to the increased
binding of RBP-Jκwith the HIF-1α complex thereby driving RTA
expression (Zhang et al., 2014). KSHV encoded latent proteins;
LANA and vIRF3 stabilize HIFα through protein-protein
interaction (Cai et al., 2006; Shin et al., 2008). The stabilization
of HIF1α through LANA has also been seen in the samples from
the patients with KS (Long et al., 2009). Furthermore, VEGF
expression has been reported to be upregulated through vGPCR
via HIF1α induction during KSHV infection (Sodhi et al., 2000).
Altogether, it is clear from the above studies that KSHV controls
HIF1α expression for a successful establishment of infection.
Wnt Signaling Pathway
The modulation of host immune system through KSHV includes
the usage of cellular signaling components belonging to Wnt
pathway. KSHV manipulates Wnt signaling cascade in order
to drive the transcription of its own genes, which modulates
downstream signaling after entry into the host cells. The
involvement of LANA in the stabilization of β-catenin is
conducted through its interaction with GSK-3β thereby trans-
locating GSK-3β to the nucleus. This suppresses β-catenin
phosphorylation in the cytoplasm and therefore leads to an
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increased TCF/LEF-dependent transcription (Fujimuro and
Hayward, 2003, 2004). The involvement of KSHV encoded
protein vGPCR in the activation of canonical Wnt/β-catenin
signaling pathway has been reported in one of the recent studies
(Angelova et al., 2014). The host cellular proteins I-mfa (inhibitor
of MyoD family), I-mfa domain proteins and HIC (human I-
mfa domain-containing protein) negatively regulate the activity
of LANA in suppressing GSK-3β activity and also by inhibiting
Wnt signaling activated by LANA (Kusano and Eizuru, 2010).
Thus, KSHV mediated cellular transformation is controlled by
LANA dependent β-catenin dysregulation.
LANA Mediated Suppression of Lytic
Reactivation
It has been proposed that LANA negatively regulates the
transcription of viral lytic genes during the establishment of
latency (Li et al., 2008). LANA inhibits RTA expression, one of
the key viral lytic genes, by repressing the transcriptional activity
of RTA promoter, where LANA associates with recombination
signal sequence-binding protein Jκ (RBP-Jκ) and represses
the RTA promoter through the RBP-Jκ binding site existing
within its promoter (Lan et al., 2004, 2005; Lu et al., 2006).
Another transcriptional repressor that controls chromosomal
remodeling, Krüppel-associated box domain-associated protein
1 (KAP1), has been identified to play an important role in
regulating KSHV latency by associating with the transcriptional
promoters and repressing the lytic gene expression (Chang
et al., 2009). In recent studies it has been proved that LANA
can recruit KAP1 to the RTA promoter region of the KSHV
genome to silence the expression of lytic genes to facilitate the
establishment of KSHV latency (Sun et al., 2014a). Recent studies
also suggested an involvement of LANA in the regulation of
SUMOylation, its interaction with the protein related to post-
translational modification of histones by the small ubiquitin-
like modifier (SUMO), plays an important role in epigenetic
control of gene transcription, DNA repair and replication (Cai
et al., 2013). LANA contains a unique SUMO-interacting motif
(LANASIM) specific for its interaction with SUMO-2 and hence
describes the first mechanism where the latent protein selectively
recruits a cellular transcriptional complex for viral episome
maintenance, modulation of viral chromatin leading to gene
silencing during latent infection (Cai et al., 2013; Chang and
Kung, 2014).
vCyclin
vCyclin (vCYC) encoded by ORF72 is a viral homolog of cellular
cyclin D, forms an active kinase complex with cellular cyclin-
dependent kinase 6 (CDK6) and regulates cell cycle and cell
proliferation by phosphorylating pRb protein, histones H1, CDK
inhibitor (cdki), and p27 (Kip1) through vCyclin-CDK6 complex
formation (Direkze and Laman, 2004; Van Dross et al., 2005).
Thus, vCyclin might contribute to KSHV latency by promoting
cellular proliferation. Studies show that vCyclin-CDK6 complex
also mediates phosphorylation of nucleophosmin (NPM) to
facilitate the interaction of NPM with LANA for the recruitment
of HDAC1 to promote KSHV latency (Sarek et al., 2010).
vFLIP
vFLIP (viral Fas-associated protein with death domain-
like interleukin-1β-converting enzyme/caspase-8-inhibitory
protein), also known as K13, encoded by ORF71 interacts with
several NF-κB-related signaling proteins and activates one of the
key cellular survival pathways, the NF-κB pathway, in latently
infected PEL cells to enhance cell proliferation and survival
during latency by inhibiting viral lytic replication (Guasparri
et al., 2004; Ye et al., 2008). This is achieved via binding to the
inhibitor of kB-kinase γ (IKK γ) thus leading to an activation of
the NF-κB pathway (Israël, 2010). It was also shown that KSHV
mutant lacking the vFLIP gene inhibits the expression of RTA
and suppress KSHV lytic cycle (Yang et al., 2011).
K12/Kaposins
Kaposins are another set of viral proteins expressed during
latency, are comprised of Kaposin A, B, and C (Sadler et al., 1999).
Amongst Kaposins, Kaposin B has been reported to promote
tumor microenvironment by increasing cytokine expression; via
it’s binding with MK2 and activation of p38/MK2 pathway,
resulting in the inhibition of cytokine mRNA degradation
(McCormick and Ganem, 2005).
Viral microRNAs (miRNAs)
These are single-stranded 20–23 nucleotide long noncoding RNA
molecules involved in gene expression, which play critical role
in the maintenance of KSHV latency by regulating the viral
lytic genes and the host survival pathways (Boss et al., 2009; Lei
et al., 2010a). The latency locus of KSHV genome encodes 12
pre-miRNAs, that further produce 18 mature miRNAs, and are
highly conserved in all isolates of KSHV (for review, see Marshall
et al., 2007; Uppal et al., 2014). All these KSHV miRNAs regulate
several cellular factors such as NF-κB and IκBα, target RTA and
inhibit the activation of viral lytic gene promoters and contribute
toward the expression of latent genes (Feldman et al., 2014).
miRNA Mediated Cellular Signaling
KSHV encodes 12 pre-miRNAs generating 18 different highly
conserved miRNAs (a single-nucleotide-edited miRNA, 16
different 5p or 3p miRNAs; Marshall et al., 2007; Lin et al.,
2010). Maintenance of KSHV latency after infection requires the
interaction of these virally encoded miRNA with various cellular
factors. Among the viral miRNAs, miR-K12-11 suppresses
BACH-1 by inducing xCT expression in the macrophages and
endothelial cells infected with KSHV (Qin et al., 2010b) and
miR-132 suppresses the expression of p300 (transcriptional
coactivator) thereby regulates the innate antiviral immunity
(Lagos et al., 2010). Also, the suppression of CXCR4 expression
is mediated through miR-146a upregulation driven by viral
FLICE inhibitory protein vFLIP (Punj et al., 2010). Apart from
this KSHV miRNA suppresses the expression of leucine zipper
transcription factor MAF (musculoaponeurotic fibrosarcoma
oncogene homolog) after infection (Hansen et al., 2010). Also,
the virally encoded miRNAs can suppress the protein expression
of breakpoint cluster region by upregulating Rac1 activity.
Additionally, Bcr knockdown in BCBL-1 cells (KSHV infected
latent cells) showed an increase in RTA levels suggesting a
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contribution of KSHVmiRNA in lytic reactivation (Ramalingam
et al., 2015). The functional roles of KSHV miRNA (miR-K1)
includes a downregulation of p21 expression thereby leading
to the attenuation of cell cycle arrest generated through p21
(Gottwein and Cullen, 2010). miR-K1 is also involved in the
regulation of both host and viral factors. It can regulate IκBα
(NF-κB inhibitor) and the replication of virus by targeting the
3′UTR of its transcripts (Lei et al., 2010b). According to one
of the studies, the cluster of KSHV miRNAs can suppress the
transcription of ORF50 (RTA) (Lu et al., 2010). Based on these
studies, it could be concluded that KSHV encoded miRNA plays
a significant role in the establishment of persistent viral infection.
MECHANISM OF KSHV LATENT DNA
REPLICATION
In order to perpetuate itself in the host during latency, KSHV
genome has to be duly replicated and accurately passed onto the
daughter cells (Ballestas et al., 1999; Cotter and Robertson, 1999;
Barbera et al., 2006). LANA is essential for genome maintenance
as well as partitioning of the episomes into the dividing cells
(Collins and Medveczky, 2002; Ye et al., 2004). LANA directly
binds to the TR region through its carboxy-terminus and
associates with components of the human chromatin at its
amino-terminus (Cotter and Robertson, 1999; Ballestas and
Kaye, 2001; Barbera et al., 2006). During latency KSHV effectively
maintains 50–100 genome copies per infected cell through highly
coordinated replication of the viral genome along with the
cellular DNA (Ueda et al., 2006; Verma et al., 2007b; Ballestas and
Kaye, 2011). LANA interacts with and recruits various cellular
proteins, for genome replication and segregation (Ballestas et al.,
1999; Barbera et al., 2006; Cotter and Robertson, 1999). KSHV
genome assembles host cellular replication machinery at the TR
and other parts of the viral genome in a cell cycle dependent
manner (Verma et al., 2007b; Uppal et al., 2014).
DNA Replication Licensing
Cellular replication is a complex multi-step process and is
precisely controlled by a replication licensing system that
regulates cells to replicate only once every cell cycle (Tsuyama
et al., 2005). DNA replication licensing is controlled by
sequential assembly of several pre-replication complex (pre-
RC) proteins onto origin of replication (ori), including origin
recognition complex (ORC), Cdc6, Cdt1, andmini-chromosomal
maintenance (MCM) helicase MCM 2-7 (Tsuyama et al., 2005).
The replication-licensing complex is initiated during G1 phase,
by direct binding of origin recognition complex (ORC) to the
ori site followed by Cdt1 (Nishitani and Lygerou, 2002). This
complex then recruits ring-shaped Mcm2-7 hexamers to the
double stranded DNA, followed by cyclin dependent kinase 2
(CDK2) and CDC7, thereby inducing a necessary change in
conformation to generate a pair of bidirectional replication forks
which in turn recruit the replication factors, leading to the
formation of an active replication complex (Hodgson and Blow,
2002; Nishitani and Lygerou, 2002). Further, to restrict DNA
replication once per cell cycle, pre-RC is disassembled from the
origins after the replication is initiated (Tsuyama et al., 2005).
In addition cellular Cyclins and Geminins also inactivate Cdt1
to prevent the reassembly of pre-RC to restrict re-replication in
same cell cycle (May et al., 2005).
Generally in eukaryotic cells, DNA replication is initiated
simultaneously at multiple replication origins on a chromosome
to complete the process within a stipulated time (Huberman and
Riggs, 1966;Wyrick et al., 2001). However various studies suggest
that not all origins are activated simultaneously, the frequency
and timing of DNA replication is tightly regulated by the extent
of heterochromatin at different cell cycle stages (Dimitrova and
Gilbert, 1999; Klochkov et al., 2009; Schwaiger et al., 2010).
The replication timing of KSHV genome is not fully understood
(Ohsaki and Ueda, 2012). Recent studies using single molecule
analysis of replicated DNA (Adam et al., 2015), demonstrated
that KSHV genome also can initiate replication at multiple points
throughout its genome along with the TR region (Verma et al.,
2011). Nonetheless, KSHV TR region is significant in latent DNA
replication, since TR contains a well-defined origin of replication,
ori-P (Hu and Renne, 2005; Verma et al., 2007b; Ohsaki and
Ueda, 2012). It is suggested that LANA dependent latent DNA
replication at ori-P is most probably initiated at the middle or late
S phase of the cell cycle (reviewed in Ohsaki and Ueda, 2012).
KSHV ori-P
KSHV ori-P consists of two LANA-binding sites (LBS) LBS-
1/2 (Hu and Renne, 2005; Verma et al., 2007a) and a 32-
bp GC-rich segment (32-GC) (reviewed in Ohsaki and Ueda,
2012). KSHV encoded LANA is indispensable during latency
and plays a crucial role in KSHV latent DNA replication.
LANA binds directly to LBS-1/2 and the ori-P, with varying
degrees of affinity (Garber et al., 2001; Grundhoff and Ganem,
2003; Hu and Renne, 2005). In cell culture system, it has been
shown that expression of KSHV LANA alone is capable of
maintaining and replicating KSHV TR containing episomes and
synthetic plasmids (Ballestas and Kaye, 2001; Hu et al., 2002;
Grundhoff and Ganem, 2003). KSHV encoded LANA, comprises
of at least four functional domains: an N-terminal proline-rich
chromosome binding region (CBD); a long glutamic acid-rich
internal repeat domain; a putative leucine zipper region and
a carboxy-terminal, TR binding domain (DBD) (Verma et al.,
2007c; Ponnusamy et al., 2015). The C-terminal DBD binding
region is capable of both dimerization and subsequent binding
to specific LANA binding sequences (LBS-1, -2, and 32GC)
to support ori-P replication (Hu et al., 2002; Ohsaki et al.,
2009). The LBS sites within KSHV TR region are reiterating
tandem sequences, therefore LANA needs to oligomerize for
its cooperative association with LBS (Ballestas and Kaye, 2001;
Komatsu et al., 2004; Domsic et al., 2013; Hellert et al., 2015).
A recent study by Li et al showed that dorsal positively charged
electrostatic patch within the LANA DBD plays a crucial role in
KSHV latent DNA replication and genome maintenance (Han
et al., 2010). LANA DBD interacts with BET (Bromodomain and
Extra Terminal domain) family of proteins (Ottinger et al., 2006;
You et al., 2006), comprising of BRD2, BRD3, and BRD4, which
are known to associate with acetylated histones (Li et al., 2015).
BET family of proteins are transcriptional regulators, which play
an important role in cell cycle control. Through their N terminal
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Bromodomain, BRD2/RING3; directly associate with acetylated
histone H4 on the chromosome. The extra-terminal domains
provide additional docking station for several other proteins to
bind to the chromatin (Pamblanco et al., 2001; Dey et al., 2003;
Kanno et al., 2004; You et al., 2004). Brd2/RING3, regulates
cell cycle through its interaction with E2F by stimulating the
G1/S transition of the cell cycle (Denis et al., 2000). LANA is
further shown to recruit BRD2/RING3 to chromatin through
amino acids residues 1007 and 1055 (Platt et al., 1999; Mattsson
et al., 2002; Ottinger et al., 2006). Furthermore, structural studies
validated the functional significance of LANA DBD binding to
LBS 1-2 (Hellert et al., 2015; Ponnusamy et al., 2015). Recent
studies show that LANA DBD oligomerizes in vitro and binds
to the LBS-1 and 2 and the binding induces a significant
conformational change in the terminal repeat DNA (Ponnusamy
et al., 2015). Apart from its association with LBS sequence, LANA
interacts with various cellular factors and recruits host cellular
machinery to effectively orchestrate the latent DNA replication
(Si et al., 2006; Ballestas and Kaye, 2011).
Viral DNA Replication
KSHV replication is initiated by the direct association of
LANA to the origin of latent DNA replication, ori-P, which
in turn triggers the recruitment various components of
the pre-replication complex (pre-RC) proteins to ori-P. The
sequential assembly of pre-replication complex, including origin
recognition complex (ORC), poly (ADP-ribose) polymerase
1 (PARP1), cell division cycle (Cdc6), and minichromosome
maintenance proteins (MCM) within the nuclear matrix region,
serves as the site of KSHV latent DNA replication in late G1
phase, (Figure 3; Lim et al., 2002; Ohsaki et al., 2004; Stedman
et al., 2004; Verma et al., 2006).
Increasing evidences indicate that LANA DBD specifically
recruits origin recognition complex (ORC2), Bromodomain
Containing 2 (BRD2), H4-specific histone acetylase (HBO1), and
CREB-binding protein (CBP) at the TR region (Stedman
et al., 2004; Verma et al., 2006). Immediately after the
recruitment of ORCs, DNA replication licensing factors
including minichromosome maintenance proteins (MCM 2-7),
which are putative helicases are assembled at the origin of
replication (Stedman et al., 2004; Lei, 2005). LANA was found to
be crucial for the recruitment of MCM3 to the TR, additionally
siRNA mediated knock down of MCM3 expression showed
significant reduction in TR-mediated replication (Stedman et al.,
2004). Similarly, LANA was also shown to augment the loading
of PCNA onto the DNA through its interaction with replication
factor C (RFC) ATPase, thus contributing to the replication
and persistence of the viral DNA (Sun et al., 2014b). PCNA is
a homotrimer, which encircles the DNA and interacts with the
DNA polymerase to bring them in close proximity to increase
its processivity (Moldovan et al., 2007). A recent study showed
that siRNAmediated depletion of RFC ATPase compromised the
interaction between RFC and LANA and directly affected LANA-
mediated replication and episome maintenance (Moldovan
et al., 2007). Similarly, it has been shown that cellular mitotic
checkpoint kinase, Bub1 plays a significant role in LANA
mediated recruitment of PCNA to the TR to initiate viral
FIGURE 3 | Schematic representation of KSHV latent DNA replication
initiation. KSHV genomes replicate once per cell cycle during latent DNA
replication and are perpetually segregated into the daughter cells. KSHV
heavily depend on host cellular machinery for its latent DNA replication. Latent
DNA replication is initiated by the direct association of LANA to LBS1/2 within
the origin of latent DNA replication, ori-P, thereby triggering the recruitment
various components of replication licensing and pre-replication complex
(pre-RC) proteins to ori-P. The sequential assembly of pre-replication complex,
including origin recognition complex (ORC), cell division cycle (Cdc6), Cdt1
and minichromosome maintenance proteins (MCM) within the nuclear matrix
region initiate KSHV latent DNA replication.
replication in S phase (Sun et al., 2015). Bub1 establishes a
molecular complex with PCNA and LANA and was found to
be critical to promote LANA mediated mono-ubiquitination
of PCNA (Sun et al., 2015). Two more cellular proteins shown
to be critical for KSHV genome replication and maintenance
are the components of Timeless-dependent DNA replication
fork protection complex, Tim and Tipin (Dheekollu et al.,
2013). These components are recruited to the TR in a LANA-
dependent manner, suggesting their role in recombination-like
structures formed during latent DNA replication (Dheekollu
et al., 2013). Our studies have shown that LANA CBD specifically
recruits cellular Topoisomerase II (TopoIIβ) to the TR region
(Purushothaman et al., 2012). Topoisomerase II (TopoIIβ) is
known to regulate and modify the DNA topology by introducing
double-stranded breaks in DNA (Purushothaman et al., 2012).
LANA localizes with the TopoIIβ in the nuclei of KSHV infected
cells. Additionally LANA mediated recruitment of TopoIIβ to
TR was also found to be critical for KSHV DNA replication
Frontiers in Microbiology | www.frontiersin.org 7 February 2016 | Volume 7 | Article 54
Purushothaman et al. KSHV Genome Replication
in KSHV infected cells as well as transient replication system.
Furthermore, KSHV infected cells treated with ellipticine, a
TopoIIβ inhibitor, significantly reduced TR mediated replication
(Purushothaman et al., 2012). These studies clearly indicate that
LANA recruits multiple components of the cellular replication
machinery at the origins within the TR to initiate latent DNA
replication.
KSHV ori-A
Accumulating evidence suggest that, KSHV latent DNA
replication also can be initiated at multiple origins, other than
ori-P (Verma et al., 2007b, 2011). Analysis of KSHV genome
using Single Molecule Analysis of Replicated DNA (Verma
et al., 2011; Adam et al., 2015), we identified an additional
replication origin (ori-A), which did not require LANA for
replication (Verma et al., 2011). SMARD is an ingenious method
to accurately detect the origin and direction of fork progression
on the replicating DNA, metabolically labeled with nucleoside
analogs IdU and CldU (Norio and Schidkraut, 2001; Verma
et al., 2011). SMARD analysis on the whole KSHV genome,
during latent replication, determined that multiple sites in
the genome could initiate replication rather than a specified
region (Verma et al., 2011). Additionally, ChIP assay for
ORC2 and MCM3 further confirmed the recruitment of these
pre-replication complexes (pre-RC) at multiple genomic sites,
confirming the formation of functional origins at those sites
(Verma et al., 2011). However, these experiments consistently
showed slight preference for replication initiation within the TR
region. This data suggests that TR region of the KSHV genome
have additional role in KSHV biology along with replicating
the genome in a LANA dependent manner (Verma et al.,
2011). Thus, KSHV latent DNA replication utilizes the cellular
machinery to pursue a replication mechanism similar to the host
DNA to maintain a life-long persistence (Verma et al., 2011).
KSHV GENOME SEGREGATION
KSHV genomes replicate once per cell cycle in latent cells
and are perpetually segregated into daughter cells along with
host chromosomes during cell division (Ballestas et al., 1999;
Barbera et al., 2006; Ueda et al., 2006). It has been shown that
LANA associates with mitotic chromatin and plays a significant
role in the maintenance of viral episomes during persistent
infection (Ballestas et al., 1999; Cotter and Robertson, 1999;
Tetsuka et al., 2004). The episomal tethering and segregation is
effectively regulated by the specific association of LANA with
histones (H2A/H2B) (Barbera et al., 2006; Verma et al., 2013)
and a methyl CpG-binding protein (MeCP2) (Griffiths and
Whitehouse, 2007; Matsumura et al., 2010; Verma et al., 2013)
through its N-terminal chromosome binding region (CBD).
Histones are small, conserved basic proteins that are involved
in the organization of nucleosomes, the basic repeating units of
condensed chromatin. Each core unit comprises two copies of
histone H2A, H2B, H3, and H4 with 147 base pairs of DNA
wrapped around this core particle. The nucleosomes are linked
together by histone H1, which is also called the linker histone
(Campos and Reinberg, 2009). It has been shown that LANA
N terminus (LANA 1-32) directly interacts with histones H2A
and H2B (H2A/B) (Luger et al., 1997; Cotter and Robertson,
1999). A recent study, further found that H2AX, an isoform
of H2A can also interact with N and C terminals of LANA
and contributes toward the phosphorylation of H2AX thereby
aiding in binding of LANA at the TRs (Jha et al., 2013).
Similarly, both LANA-N and LANA-C termini also were found
to interact with MeCp2 and this association is suggested to favor
the maintenance and segregation of KSHV genome (Krithivas
et al., 2002). Methyl CpG binding protein 2 (MeCP2) is a
nuclear protein, which specifically binds to methylated CpG
dinucleotides and plays a key role in the transcriptional silencing
of genes in CpG-methylated regions, activation of euchromatic
genes, and mRNA splicing (Meehan et al., 1992; Nan et al.,
1997; Aravind and Landsman, 1998). MeCP2 was also found
to enhance the LANA-mediated activation of E2F1 promoter
(Matsumura et al., 2010). Furthermore, LANA also interact with
yet another nuclear protein DEK through the C-terminal DNA
binding region (DBD), which is suggested to play a crucial role in
KSHV genome tethering (Alexiadis et al., 2000; Krithivas et al.,
2002). DEK has been shown to specifically interact with histones
H2A, H2B, H3, and H4 during G1/S phase (Alexiadis et al., 2000;
Waldmann et al., 2004). Direct interaction of LANA with DEK
and DBD of LANA being the specific DEK binding domain,
seemed to be crucial for KSHV genome tethering and segregation
(Krithivas et al., 2002).
Additionally, LANA has been shown to interact with various
nuclear matrix proteins required for the maintenance of
nuclear architecture during mitosis, such as nuclear mitotic
apparatus protein (NuMA), centromeric protein F (CENP-F) and
kinetochore protein, Bub1 (Si et al., 2008; Xiao et al., 2010; Verma
et al., 2013). NuMA is a nuclear-coiled coil protein, which is
critical for organization of spindle apparatus and segregation of
dividing nuclei during cell division (Guse et al., 2011). NuMA
also plays a central role in DNA replication and transcription
through its interaction with matrix attachment regions as well
as the splicing factors, snRNPs (Doxsey et al., 2005). NuMa has
been shown to be essential for persistence of KSHV genomes
and their distribution to the daughter cells through its interaction
with LANA at its C terminus and this association also requires the
presence of dynein/dynactin and microtubules (Si et al., 2008).
During interphase NuMA interacts with LANA through its C-
terminus and plays a crucial role in the maintenance of nuclear
architecture for episome segregation (Si et al., 2008). Immediately
after the disintegration of nuclear envelope NuMA is hyper
phosphorylated and moved to the spindle poles to secure the
spindle microtubules to each pole (Merdes et al., 1996; Gehmlich
et al., 2004). Importantly, NuMA knockdown has been shown
to severely affect episome segregation as well as TR mediated
genome maintenance (Si et al., 2008). Similarly, it has been
shown that kinetochore proteins, Bub1 and CENP-F interact
with the centromere and serve as the docking site of the spindle
microtubules (Guse et al., 2011). Since centromeres are absent
on viral genomes, association of KSHV LANA with kinetochore
proteins, Bub1 and CENP-F are crucial for the segregation of
episomes during cell division (Xiao et al., 2010). Both the N-
terminal and C-terminal domains of LANA have been shown to
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interact with Bub1 and CENP-F (Xiao et al., 2010). These data
strongly suggest that several proteins with in the nuclear matrix
play significant role during KSHV DNA replication as well as
genome segregation during mitosis (Xiao et al., 2010).
SUMMARY
Kaposi’s sarcoma-associated herpesvirus (KSHV) persists
predominantly as a latent episome in the infected cells. The
latency-associated nuclear antigen (LANA) encoded by KSHV
plays a central role in episome tethering, replication, and
segregation of episomes during cell division. KSHV genome
replicates once per cell cycle during latent replication and
depends fully on cellular replication machinery for replication
and genome maintenance. KSHV genome consists of LANA
dependent replication origin, ori-P, within the TR region as
well as additional replication sites distributed throughout
the genome. ori-P consists of two LANA-binding sites (LBS)
LBS-1/2 and a 32-bp GC-rich segment (32GC). KSHV encoded
LANA is indispensable during latency and plays a crucial role
in the replication mediated by ori-P. LANA binding to LBS
sequence specifically recruit cellular replication factors to viral
replication origin (ori-P) to initiate replication. KSHV recruits
cellular pre-replication complexes (pre-RC) components such
as origin recognition complexes (ORCs), cell division cycle
(Cdc6) proteins and minichromosome maintenance proteins
(MCM) to the ori-P. Additionally, LANA interacts with various
nuclear matrix proteins required for the maintenance of
nuclear architecture during mitosis, such as nuclear mitotic
apparatus protein (NuMA), centromeric protein F (CENP-F)
and kinetochore protein (Bub1). These specific interactions
proved to be critical for the effective segregation of episomes
into daughter cells. Taken together, the currently available data
strongly suggests that KSHV LANA recruits several cellular
proteins within the nuclear matrix to facilitate KSHV latent
DNA replication as well as genome segregation during cell
division.
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